Platform
Company
Coagulation
Review status
Currently under review
Pending specialist review and validation.
Factor V is a clotting protein that helps your blood form stable clots. The Factor V activity test measures how well this protein works in your plasma using a standard clot-based method that compares your sample with plasma that lacks factor V. The label reflects the dilution used during the assay, which is part of the laboratory method and not something you need to prepare for.
This test evaluates function, not genetics. It is different from tests for the factor V Leiden variant, which look for a genetic change linked to an increased risk of blood clots.
Clinicians order this test when there is unexplained bleeding, easy bruising, or abnormal screening clotting tests, and to help distinguish reduced clotting factor production from vitamin K related issues. Because factor V is made in the liver and is not vitamin K dependent, the result can help your clinician assess liver function, consumption of clotting factors, or the presence of an inhibitor to factor V.
It may also be used to evaluate suspected inherited factor V deficiency, to investigate bleeding after procedures, or to monitor recovery after treatments such as plasma transfusion. This assay is not used to assess the factor V Leiden variant; that requires a different laboratory or genetic test.
A lower than expected activity result suggests a deficiency or inhibition of factor V. Your clinician will consider your symptoms, medications, and other lab results, and may order follow-up testing such as a mixing study, a specific inhibitor screen, or a factor V antigen assay. If an acquired inhibitor is suspected, further evaluation and targeted treatment may be needed.
A normal or near-normal activity result usually indicates that factor V function is adequate at the time of testing. If results are unexpected, your clinician may recommend repeating the test, testing when you are not taking interfering anticoagulants, or evaluating for conditions such as liver disease or disseminated intravascular coagulation. This assay does not diagnose factor V Leiden; if there is concern about a clotting tendency, your clinician may order activated protein C resistance or genetic testing.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Heparin and direct oral anticoagulants can interfere with clot-based factor assays and may cause falsely low or high readings depending on the reagent. Do not stop medication unless your clinician advises a safe plan.
Underfilled citrate tubes, high hematocrit, clots in the sample, or delays in processing can distort results. Proper filling, rapid centrifugation, and prompt freezing or testing help ensure accuracy.
Factor V is produced in the liver and can be reduced in liver dysfunction or consumed during severe illness such as disseminated intravascular coagulation. Results are best interpreted alongside other liver and coagulation tests.
Acquired antibodies that neutralize factor V can lower measured activity and may cause bleeding. Mixing studies and inhibitor assays can help distinguish deficiency from inhibition.
Transfusion of plasma or complex concentrates can temporarily raise factor levels and mask an underlying deficiency. Tell your clinician about any recent treatments.
Physiologic changes in pregnancy and with estrogen therapy can alter coagulation test results. Your clinician will interpret the activity result in that context.
References